Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PerkinElmer Expands Reagent Portfolio | Contract Pharma

What are you searching for?

Sign in
Breaking News

PerkinElmer Expands Reagent Portfolio

Uses AlphaLISA technology to help improve safety testing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PerkinElmer, Inc. has launched a new range of assay kits using AlphaLISA technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs. PerkinElmer developed the new assays to help meet the stringent performance requirements relating to drug impurities and toxic effects.
 
According to the company, the AlphaLISA technology helps to achieve higher quality results than the comparable ELISA (enzyme-linked immunosorbent assay) technology in half the time, and has a simple protocol with fewer assay steps, resulting in better inter- and intra-assay precision, improved coefficient of variations (CVs), and easier method transfer to downstream departments.
 
“PerkinElmer is continuously seeking new ways to improve human health through the development of innovative technologies,” said Kevin Hrusovsky, president, Life Sciences and Technology, PerkinElmer. “Adverse reactions due to drug toxicity comprise a real issue that we are passionate about helping to minimize. We are very excited to enable our customers to improve the safety and efficacy of new biotherapeutic drugs being developed through our new assay kits which are the latest addition to our growing biotherapeutics portfolio.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters